Publications by authors named "Jun Naniwa"

Claim this Profile
T
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.
Tetsuro Oishi, Hiroaki Itamochi, Akiko Kudoh, Michiko Nonaka, Misaki Kato, Jun Naniwa

Oncol Rep· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy.
Kazunori Uegaki, Muneaki Shimada, Seiya Sato, Imari Deura, Jun Naniwa

Int J Clin Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of phosphatidylinositol 3'-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach for mucinous adenocarcinoma of the ovary.
Akiko Kudoh, Tetsuro Oishi, Hiroaki Itamochi, Seiya Sato, Jun Naniwa

Int J Gynecol Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.
Hiroaki Itamochi, Mayumi Nishimura, Nao Oumi, Misaki Kato, Tetsuro Oishi, Jun Naniwa

Int J Gynecol Cancer· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.
Hiroaki Itamochi, Misaki Kato, Mayumi Nishimura, Nao Oumi, Tetsuro Oishi, Jun Naniwa

Hum Cell· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2.
Hiroaki Itamochi, Misaki Kato, Mayumi Nishimura, Tetsuro Oishi, Muneaki Shimada, Jun Naniwa

Hum Cell· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
Michiko Nonaka, Hiroaki Itamochi, Wakae Kawaguchi, Akiko Kudoh, Seiya Sato, Jun Naniwa

Int J Gynecol Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.
Hiroaki Itamochi, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Kazunori Uegaki, Jun Naniwa

Clin Cancer Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative and intraoperative assessments of depth of myometrial invasion in endometrial cancer.
Shinya Sato, Hiroaki Itamochi, Muneaki Shimada, Shinya Fujii, Jun Naniwa

Int J Gynecol Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Seiya Sato, Hiroaki Itamochi, Junzo Kigawa, Tetsuro Oishi, Muneaki Shimada, Jun Naniwa

Cancer Sci· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells.
Kazunori Uegaki, Yasunobu Kanamori, Junzo Kigawa, Wakae Kawaguchi, Ruri Kaneko, Jun Naniwa

Cell Tissue Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
Kazunori Uegaki, Yasunobu Kanamori, Junzo Kigawa, Wakae Kawaguchi, Ruri Kaneko, Jun Naniwa

Oncol Rep· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer.
Takahiro Iba, Junzo Kigawa, Yasunobu Kanamori, Hiroaki Itamochi, Tetsuro Oishi, Jun Naniwa

Cancer Sci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
Shinya Sato, Junzo Kigawa, Yasunobu Kanamori, Hiroaki Itamochi, Tetsuro Oishi, Jun Naniwa

Cancer Chemother Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomycin B enhances CDDP-sensitivity via nuclear accumulation of p53 protein in HPV-positive cells.
Jun Naniwa, Junzo Kigawa, Ryoji Akeshima, Yasunobu Kanamori, Hiroaki Itamochi

Cancer Sci· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis